This week, CBS News reported that Moderna's early data from their vaccine trials show 94.5% efficacy, with 5 vaccine recipients included in the trial's 95 confirmed cases, and reinforces last week's news from Pfizer of greater than 90% efficacy (revised a few days later to closer to 95%).

Private practice and urgent care patients can benefit from rapid flu testing.

[case_player][/case_player] Scientists at École Polytechnique Fédérale de Lausanne (EPFL) have developed a small laboratory-in-a-box capable of housing and feeding a colony of C. elegans nematodes (roundworms) and testing the effects of cosmetics, drugs, and other substances to determine their toxicity...